Related Experiment Videos
[Characteristics of blood coagulation changes in patients with dilated cardiomyopathy]
Insights
This study investigated thrombogenesis in dilated cardiomyopathy, finding altered blood clotting and reduced platelet function. Increased fibrinolysis suggests a complex interplay of factors contributing to clot formation in these patients.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Pathophysiology
Context:
- Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
- Thrombogenesis, the process of clot formation, is a critical concern in cardiovascular diseases.
- Understanding the specific hemostatic alterations in DCM is crucial for risk stratification and management.
Purpose:
- To investigate the pathogenetic factors of thrombogenesis in patients with dilated cardiomyopathy.
- To evaluate key hemostatic parameters including coagulogram, fibrinolysis, and platelet adhesive-aggregational properties.
Summary:
- Forty patients with dilated cardiomyopathy underwent comprehensive hemostatic evaluation.
- Findings revealed mixed coagulation states (hypo- and hypercoagulation) and a decreased platelet count.
- Platelet adhesiveness remained unchanged, but aggregation and deaggregation capacities were reduced.
- A notable increase in general plasma fibrinolytic activity was observed.
Impact:
- Identifies specific hemostatic abnormalities contributing to thrombogenesis in DCM.
- Provides insights into the complex pathophysiology of clot formation in this patient population.
- May inform future therapeutic strategies targeting thrombotic risk in dilated cardiomyopathy.
Abstract:
The main indices of the coagulogram, fibrinolysis and adhesive-aggregational properties of thrombocytes were evaluated in 40 patients with dilated cardiomyopathy with the purpose of determining the pathogenetic factors of thrombogenesis. Hypo- and hypercoagulation changes were found as well a reduction of the number of thrombocytes while the adhesiveness index remained unchanged; the aggregation and deaggregation capacities of thrombocytes reduced, the general fibrinolytic plasma activity increased.